STOCKHOLM: Sweden’s Public Well being Company mentioned on Monday it really helpful using Pfizer-BioNTech’s , Comirnaty vaccine towards COVID-19 for youngsters between 12-15, opting towards rival Moderna’s Spikevax.
The Eu Drugs Company licensed using Comirnaty in Would possibly, whilst Spikevax was once given the nod for youngsters over 12 in July.
“All in all, we see reason why to select the vaccine that we all know essentially the most about and that’s maximum well-proven in relation to vaccinating youngsters between 12 and 15 years of age,” Anders Tegnell, head of division and state epidemiologist on the Well being Company mentioned.
The company mentioned there was once extra knowledge about Comirnaty’s use on youngsters.
“That is why Spikevax isn’t really helpful for the youngest age team in Sweden,” the Company mentioned in a remark. In September, the Company mentioned that kids elderly 12 and over could be introduced a COVID vaccination beginning October 11.
